Summary
Based on observations with the novel dopamine-receptor agonist 3-(3-hydroxyphenyl-)-N-n-propylpiperidine, 3-PPP, especially its levorotatory enantiomer, it is proposed that the intrinsic activity of a receptor agonist depends in part on the responsiveness of the receptor; this in turn is determined by the degree of previous agonist occupancy on the receptor. A change in occupancy will induce a slow conformational change, influencing the responsiveness. This may constitute an important aspect of receptor adaptation and may help to explain otherwise puzzling phenomena,e.g. that compounds such as (−)-3-PPP or transdihydrolisuride can act as strong dopamine-receptor agonists in some locations and as antagonists in others.
The observations discussed in the present paper may be interpreted to indicate that the dopamine receptors in different locations are, in fact, derived from a homogeneous receptor population, though in a varying state of adaptation. Thus it may prove worth-while to reconsider the various subclassifications of DA receptors proposed so far.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Arnt, J., Christensen, A. V., Hyttel, J., Larsen, J.-J., Svendsen, O.: Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity. Eur. J. Pharmacol.86, 185–198 (1982).
Arnt, J., Bögesö, K. P., Christensen, A. V., Hyttel, J., Larsen, J.-J., Svendsen, O.: Dopamine receptor agonistic effects of 3-PPP enantiomers. Psychopharmacoloy 1983 (in press).
Carlsson, A.: Are “on-off” effects during chronic L-dopa treatment due to faulty feedback control of the nigrostriatal dopamine pathway? J. Neural Transmission 1983 (in press).
Costall, B., Kelly, M. E., Naylor, R. J.: Does contralateral circling involve action of drugs on hyposensitive striatal dopamine receptors in the hemisphere contralateral to denervation? Neuropharmacology22, 295–302 (1983).
Eriksson, E., Modigh, K., Carlsson, A.: Dopamine receptors involved in prolactin secretion pharmacologically characterized by use of 3-PPP enantiomers. Eur. J. Pharmacol. 1983 (in press).
Hjorth, S.: On the mode of action of 3-(3-hydroxyphenyl)-N-n-propylpiperidine, 3-PPP, and its enantiomers. Thesis, Göteborg, 1983, pp.1–52.
Hjorth, S., Carlsson, A., Wikström, H., Lindberg, P., Sanchez, D., Hacksell, U., Arvidsson, L.-E., Svensson, U., Nilsson, J. L. G.: 3-PPP, a new centrally acting DA receptor agonist with selectivity for autoreceptors. Life Sci.28, 1225–1238 (1981).
Hjorth, S., Carlsson, A., Clark, D., Svensson, K., Wikström, H., Sanchez, D., Lindberg, P., Hacksell, U., Arvidsson, L.-E., Johansson, A., Nilsson, J.L.G.: Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology 1983 (in press).
Laduron, P.: Dopamine receptor: a unique site with multiple postsynaptic localization. In: Apomorphine and other Dopaminomimetics, Vol. I: Basic Pharmacology (Gessa, G. L., Corsini, G. U., ed.), pp. 95–103. New York: Raven Press. 1981
Magnusson, T., Carlsson, A., Lindberg, P., Sanchez, D.: Evidence for activation of dopaminergic autoreceptors by (−)-3-PPP. In: Dopamine Receptor Agonists (Carlsson, A., Nilsson, J. L. G., eds.). Acta Pharm. Suec, Suppl.1, 16–18 (1983).
Martin, G. E., Haubrich, D. R., Williams, M.: Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99. Eur. J. Pharmacol.76, 15–23 (1981).
Seeman, P.: Brain dopamine receptors. Pharm. Revs.32, 229–313 (1980).
Wachtel, H., Dorow, R.: Dual action on central dopamine function of transdihydrolisuride, a 9,10-dihydrogenated analogue of the ergot dopamine agonist lisuride. Life Sci.32, 421–432 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carlsson, A. Dopamine receptor agonists: Intrinsic activity vs. state of receptor. J. Neural Transmission 57, 309–315 (1983). https://doi.org/10.1007/BF01249001
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01249001